###begin article-title 0
A Variation in the Cerebroside Sulfotransferase Gene is Linked to Exercise-Modified Insulin Resistance and to Type 2 Diabetes
###end article-title 0
###begin p 1
###xml 15 20 <span type="species:ncbi:4584">Anjan</span>
Recommended by Anjan Kowluru
###end p 1
###begin p 2
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aims</italic>
###xml 28 32 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 54 55 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 138 142 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 518 525 512 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 646 653 640 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 803 804 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 866 867 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 986 987 980 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1084 1085 1078 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1094 1104 1088 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusion</italic>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
###xml 682 690 <span type="species:ncbi:9606">patients</span>
###xml 1014 1021 <span type="species:ncbi:9606">persons</span>
Aims. The glycosphingolipid beta-galactosylceramide-3-O-sulfate (sulfatide) is present in the secretory granules of the insulin producing beta-cells and may act as a molecular chaperone of insulin. The final step in sulfatide synthesis is performed by cerebroside sulfotransferase (CST) (EC 2.8.2.11). The aim of this study was to investigate whether two single nucleotide polymorphisms (SNP), rs2267161 located in an exon or rs42929 located in an intron, in the gene encoding CST are linked to type 2 diabetes (T2D). Methods. As a population survey, 265 male and female patients suffering from T2D and 291 gender matched controls were examined. Results. A higher proportion of T2D patients were heterozygous at SNP rs2267161 with both T (methionine) and C (valine) alleles present (49.8% versus 41.3%, P = .04). The calculated odd risk for T2D was 1.47 (1.01-2.15, P = .047). Among female controls, the homozygous CC individuals displayed lower insulin resistance measured by HOMA-IR (P = .05) than the C/T or TT persons; this was particularly prevalent in individuals who exercise (P = .03). Conclusion. Heterozygosity at SNP rs2267161 in the gene encoding the CST enzyme confers increased risk of T2D. Females with the CC allele showed lower insulin resistance.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">1</xref>
###xml 130 135 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 137 138 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">2</xref>
###xml 154 155 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">3</xref>
###xml 157 158 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">4</xref>
###xml 224 225 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">5</xref>
###xml 338 339 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">6</xref>
Several single nucleotide polymorphisms (SNPs) have been found linked to type 2 diabetes (T2D). These include calpain 10 [1], PPARgamma [2], adiponectin [3, 4], and the Kir6.2 subunit of the ATP-sensitive potassium channel [5]. In Icelandic subjects, the transcription factor 7-like 2 (TCF7L2) was found to be strongly associated to T2D [6].
###end p 4
###begin p 5
###xml 15 19 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 41 42 38 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 94 95 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">7</xref>
###xml 96 97 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">9</xref>
###xml 114 119 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 190 192 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">10</xref>
###xml 335 337 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 339 341 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">12</xref>
###xml 515 517 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">13</xref>
###xml 701 703 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">14</xref>
The glycolipid beta-galactosylceramide-3-O-sulfate (sulfatide) modulates cytokine expression [7-9], including TNF-alpha and Interleukin 6 (IL-6) which are known to cause insulin resistance [10]. Sulfatide may also act as a molecular chaperone of insulin, being present in the secretory granules and are secreted together with insulin [11, 12]. Low sulfatide concentration in serum disposes to development of T2D with a relative risk of 2.5, and low serum sulfatide levels are correlated to high insulin resistance [13]. The cerebroside sulfotransferase (CST) (EC 2.8.2.11) catalyzes the final and rate-limiting reaction in sulfatide synthesis: the addition of a sulphate group to galactocylceramide, [14].
###end p 5
###begin p 6
The gene encoding CST is located on chromosome 22 (22q12.2). The gene encompasses roughly 22 kb and is comprised of 8 exons, 6 noncoding, and 2 coding exons. The CST cDNA, composed of 1791 bp, encodes a 423-amino acid protein with a predicted type II transmembrane topology and 2 potential N-linked glycosylation sites. At present there are 13 known SNPs in the CST gene but only one is located in a coding exon (exon 7). This variation (rs2267161) causes an amino acid shift at codon 29 alternating between methionine and valine. 
###end p 6
###begin p 7
###xml 101 109 <span type="species:ncbi:9606">patients</span>
In this study we examined the prevalence of the two SNPs rs2267161 and rs42929 in a group of 265 T2D patients and 291 healthy controls. The individuals were all examined intensively, with several clinical parameters investigated, including BMI, insulin resistance (HOMA-IR), serum sulfatide concentration, and exercise level.
###end p 7
###begin title 8
2. Methods and Subjects
###end title 8
###begin title 9
2.1. Subjects
###end title 9
###begin p 10
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">15</xref>
###xml 621 623 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">16</xref>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
###xml 689 692 <span type="species:ncbi:9606">men</span>
###xml 697 702 <span type="species:ncbi:9606">women</span>
###xml 739 742 <span type="species:ncbi:9606">men</span>
###xml 751 756 <span type="species:ncbi:9606">women</span>
###xml 894 901 <span type="species:ncbi:9606">patient</span>
###xml 1125 1137 <span type="species:ncbi:9606">participants</span>
###xml 1167 1175 <span type="species:ncbi:9606">Patients</span>
###xml 1252 1257 <span type="species:ncbi:9606">women</span>
###xml 1266 1269 <span type="species:ncbi:9606">men</span>
###xml 1287 1299 <span type="species:ncbi:9606">participants</span>
###xml 1474 1479 <span type="species:ncbi:9606">women</span>
###xml 1488 1491 <span type="species:ncbi:9606">men</span>
###xml 1540 1543 <span type="species:ncbi:9606">men</span>
###xml 1547 1554 <span type="species:ncbi:9606">patient</span>
###xml 1764 1772 <span type="species:ncbi:9606">patients</span>
###xml 1875 1878 <span type="species:ncbi:9606">men</span>
###xml 1883 1888 <span type="species:ncbi:9606">women</span>
In Skara, Sweden, a large majority of patients with hypertension and/or T2D have attended medical care programs at the local public health center during the last 30 years. During 1992-1993, 400 patients diagnosed with diabetes were given extensively examinations at the health care centre during an extended annual visit, thus participating in the baseline survey of the Skaraborg Hypertension and Diabetes Project, described in detail elsewhere [15]. From the population census register of Skara, 1400 subjects aged >/=40 years were randomly selected, stratified by age and gender to participate in a population survey [16]. From each 10-year category between 40 and 79 years of age, 150 men and women, and in the age group 80 years, 100 men and 100 women were identified. These subjects were invited to the clinic for a clinical examination according to the same protocol as in the 1993-1994 patient survey. 1109 subjects responded and completed the investigation. The Skaraborg Hypertension and Diabetes Project have been approved by the Committee on Research Ethics at the Medical Faculty of Goteborg University, and all participants gave their informed consent. Patients below 75 years of age with T2D were eligible for the present study, and 128 women and 145 men were selected as participants. From the population survey 300 control individuals conforming to the following were selected: <75 years, no evidence of T2D and fasting blood glucose level <5.6 mmol/L, 142 women and 158 men in total. Due to lack of biochemical analysis 4 men (1 patient and 3 controls) were excluded from the study at baseline, and a further 14 were excluded due to failure of genotyping; in total 136 male and 155 female controls partook, along with 139 male and 126 female T2D patients. There was a significant age difference between cases and controls, but within each group the ages of men and women were similar.
###end p 10
###begin title 11
2.2. Biomedical Data
###end title 11
###begin p 12
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">13</xref>
Body mass index (BMI), blood serum sulfatide concentrations, serum insulin concentration, and fasting blood glucose levels were obtained as described in [13].
###end p 12
###begin title 13
2.3. Homeostasis Model Assessment Test (HOMA)
###end title 13
###begin p 14
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">17</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">18</xref>
###xml 272 276 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 358 366 <span type="species:ncbi:9606">Patients</span>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
###xml 468 476 <span type="species:ncbi:9606">patients</span>
Blood samples were drawn in the morning, after 10 hours of overnight fast. Fasting blood glucose was analyzed locally by a modified glucose dehydrogenase method (Hemocue AB, Angelholm, Sweden). Using the Homeostasis Model Assessment (HOMA) [17, 18] insulin resistance and beta-cell function were assessed from the fasting glucose and insulin concentrations. Patients with fasting blood glucose levels of less than 3.5 mmol/L and patients in treatment with insulin (65 patients) were excluded from analysis of HOMA values.
###end p 14
###begin title 15
2.4. Exercise Level
###end title 15
###begin p 16
###xml 19 26 <span type="species:ncbi:4097">tobacco</span>
###xml 112 124 <span type="species:ncbi:9606">participants</span>
A questionnaire on tobacco use, alcohol consumption, and leisure time physical activity (LTPA) was given to the participants when they came to the study visit. They completed it on site and returned it to the study nurse. LTPA was characterized based on four answer alternatives to the question "How much physical activity do you engage in during your leisure time?" The question referred to the past year and the answer alternatives were as follows. (1) Sedentary leisure time: reading, TV, stamp collecting, or other sedentary activity. (2) Light LTPA: walking, cycling, or other physical activity under at least four hours per week. (3) Moderate LTPA: running, swimming, tennis, aerobic, heavier gardening, or similar physical activity during at least 2 hours a week. (4) Heavy training or competitive sport: heavy training or competitions in running, skiing, swimming, football, and so forth, which is performed regularly and several times a week.
###end p 16
###begin title 17
2.5. Polymorphism Screening
###end title 17
###begin p 18
In total, 265 T2D samples and 291 control samples were tested for the two SNPs (rs2267161 and rs42929). Genotyping was performed using multiplex PCR followed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) using SEQUENOM's MassEXTEND assay (Sequenom, San Diego, Calif, USA). Briefly, amplification of genomic DNA, forward and reverse primers specific for the sequence surrounding the two SNPs were constructed, each primer incorporated an hME-10 tag. The hME-10 primers were used in the first multiplex PCR. The amplified, DNA was then treated with shrimp alkaline phosphatase to desphosphorylate any unincorporated dNTPs and subjected to a second multiplex PCR. In the second multiplex PCR, primers specific for the DNA sequences forward or reverse up to the SNPs were used along with terminating dNTPs, specific for the polymorphic nucleotides, creating allele-specific extension products. The molecular weights of the extension products were subsequently analyzed using MALDI-TOF mass spectrometry.
###end p 18
###begin title 19
2.6. Statistics
###end title 19
###begin p 20
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical analysis was performed using SPSS 12.0.1 for Windows. Standard methods were used for descriptive statistics. All analyses were adjusted for difference in age and specified also for other covariates. Associations between categorical variables were analyzed by logistic regression and expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Differences in continuous variables were analysed with general linear models (GLMs). All tests were 2-sided, and statistical significance was assumed when P < .05.
###end p 20
###begin title 21
3. Results
###end title 21
###begin p 22
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 258 265 258 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 448 455 448 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
Association between two SNPs in the cerebroside sulfotrasferase gene and T2D was examined. Regarding the SNPs rs2267161, the heterozygotic allele C/T was found to be more frequent among the T2D patients than among the controls (49.8% versus 41.3%, P = .04) (Table 1). The odd ratio for having T2D increased from 1 (C/C) to 1.59 (confidence interval: 1.07-2.35) with the C/T genotype (P = .02), after correcting for age, sex, and physical activity (Table 2).
###end p 22
###begin p 23
###xml 116 120 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 231 232 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 250 254 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 270 271 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 310 317 304 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 470 471 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 480 487 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 4 16 <span type="species:ncbi:9606">participants</span>
###xml 448 453 <span type="species:ncbi:9606">women</span>
All participants in the study completed a homeostasis model assessment test (HOMA) for insulin resistance (-IR) and beta-cell function (-BC). In control females, subjects with the C/C genotype displayed higher insulin sensitivity (P = .02) and lower beta-cell function (P = .05) than the C/T or T/T genotypes (Table 3). Further analysis of the lower insulin resistance amongst the female controls revealed that the difference lays entirely amongst women who exercised, (P = .03) (Table 3).
###end p 23
###begin p 24
###xml 245 252 245 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab4">Table 4</xref>
###xml 49 56 <span type="species:ncbi:9606">patient</span>
Sulfatide levels were significantly lower in the patient group compared to the control group (1.96 versus 2.22), but this difference was not related to any of the genotypes, and no significant difference between the genotypes were observed (see Table 4).
###end p 24
###begin p 25
###xml 117 124 117 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab5">Table 5</xref>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Analysis of rs42929 allele frequency data revealed no significant difference between diabetic patients and controls (Table 5).
###end p 25
###begin title 26
4. Discussion
###end title 26
###begin p 27
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">19</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">20</xref>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
###xml 546 554 <span type="species:ncbi:9606">patients</span>
###xml 591 596 <span type="species:ncbi:9606">women</span>
###xml 674 679 <span type="species:ncbi:9606">women</span>
###xml 754 757 <span type="species:ncbi:9606">men</span>
Analysis of the allele frequency of the exon located SNPs rs2267161 revealed a higher proportion of T2D patients having the C/T allele than controls. Female controls with the C/C genotype displayed better insulin sensitivity and showed corresponding lower insulin secretion; exercise may be especially beneficial for these individuals as female carriers of the C/C genotype who exercised had lower insulin resistance than carriers of the other genotypes. Interestingly, the C/C allele tended to have a reduced frequency among the female diabetic patients. T2D is correlated to obesity, with women considerably more susceptible to increased risk with increasing BMI [19] and women with T2D experience a 3-fold higher risk of acute myocardial infarct than men with T2D [20]. 
###end p 27
###begin p 28
###xml 725 732 <span type="species:ncbi:9606">patient</span>
The SNPs rs2267161 causes an amino acid variance between methionine and valine. The predominant genotypes are C/C and C/T coding for valine and valine and methionine. The homozygotic T form (T/T) has the lowest frequency; that is, T is the minor allele at re2267161. Both methionine and valine are overall uncharged and have similar level of hydrophobicity. Valine has a neutral ethyl-side group, whereas methionine has a sulphanyl group. This difference might lead to conformational changes in the CST enzyme depending on which amino acid is used at SNPs rs2267161. The precise functional consequence, at enzyme level, of heterozygoticity at SNPs rs2267161 is not known, but the observed difference between controls and the patient group indicates that increased heterozygoticity confers an increased risk of T2D in the population tested.
###end p 28
###begin p 29
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CST </italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">21</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">23</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">24</xref>
Other studies have reported a possible linkage between chromosome 22 and T2D in genomewide linkage analysis using microsatellite markers encompassing the region 22q12.2 where the CST  gene is located. A UK-based study found a linkage between a loci located at position 22q11 and early onset (<45 years) T2D; the resolution in this study was an average of 9 centimorgans indicating that region 22q12 could be included [21]. A genomic scan of 516 microsatellite markers in 363 Pima Indians revealed a linkage between region 22q12-13 and fasting plasma glucose concentration [22]. In a study including 638 T2D affected African-American sib-pairs, a genomewide multipoint single-locus linkage analysis, the second highest LOD score of 1.33 was seen on chromosome 22 at 32 centimorgans (microsatellite marker D22S685)-region 22q12 [23]. A genomewide linkage search in Canadian Oji-Cree Indians using 190 microsatellite markers (resolution approximately 20 centimorgans), marker D22S683 (encompassing region 22q12) showed significant linkage to T2D [24]. Taken together these reports substantiate our finding that region 22q12 is linked to T2D prevalence.
###end p 29
###begin title 30
5. Conclusion
###end title 30
###begin p 31
###xml 95 99 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 123 125 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">25</xref>
###xml 197 199 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">13</xref>
###xml 420 423 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CST</italic>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
Sulfatide affects both the immune system (including low grade inflammation as seen in T2D) and beta-cell (pato)physiology [25], and the blood concentration of sulfatide is reduced in T2D patients [13]. We here report a connection between a specific genotype and changed insulin resistance in females, linked to exercise level, and a linkage between susceptibility to T2D and a heterozygosity in the coding region of the CST gene, the final step in sulfatide synthesis.
###end p 31
###begin article-title 32
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
###end article-title 32
###begin article-title 33
###xml 15 20 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
###end article-title 33
###begin article-title 34
###xml 19 24 <span type="species:ncbi:9606">human</span>
Association of the human adiponectin gene and insulin resistance
###end article-title 34
###begin article-title 35
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APM1</italic>
Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians
###end article-title 35
###begin article-title 36
Single nucleotide polymorphisms in KATP channels: muscular impact on type 2 diabetes
###end article-title 36
###begin article-title 37
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
###end article-title 37
###begin article-title 38
In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide
###end article-title 38
###begin article-title 39
###xml 89 94 <span type="species:ncbi:9606">human</span>
Sulphatide and its precursor galactosylceramide influence the production of cytokines in human mononuclear cells
###end article-title 39
###begin article-title 40
Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells
###end article-title 40
###begin article-title 41
Insulin resistance in type 2 diabetes-role of the adipokines
###end article-title 41
###begin article-title 42
###xml 63 66 <span type="species:ncbi:10116">rat</span>
The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking
###end article-title 42
###begin article-title 43
Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization
###end article-title 43
###begin article-title 44
Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with type 2 diabetes. The Skaraborg Project
###end article-title 44
###begin article-title 45
Metabolic and functional aspects of sulfogalactolipids
###end article-title 45
###begin article-title 46
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project
###end article-title 46
###begin article-title 47
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project
###end article-title 47
###begin article-title 48
###xml 23 27 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes
###end article-title 48
###begin article-title 49
###xml 53 57 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 130 133 <span type="species:ncbi:9606">man</span>
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
###end article-title 49
###begin article-title 50
Epidemiology, trends, and morbidities of obesity and the metabolic syndrome
###end article-title 50
###begin article-title 51
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Female advantage in AMI mortality is reversed in patients with type 2 diabetes in the Skaraborg project
###end article-title 51
###begin article-title 52
Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11
###end article-title 52
###begin article-title 53
An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians
###end article-title 53
###begin article-title 54
A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q
###end article-title 54
###begin article-title 55
Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers
###end article-title 55
###begin article-title 56
Involvement of sulfatide in beta cells and type 1 and type 2 diabetes
###end article-title 56
###begin p 57
###xml 153 155 153 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
Nucleotide frequencies at SNPs rs2267161. Note difference in frequency of C/T genotype between controls and type 2 diabetic patients. Asterisk indicates P  < .05.
###end p 57
###begin p 58
Associations between variations in the CST gene at SNPs rs2267161 and T2D. Associations were estimated using logistic regression and expressed as odds ratios (ORs) with 95% confidence intervals (CIs).
###end p 58
###begin p 59
###xml 100 102 100 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</italic>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>#</italic></sup>
###xml 120 122 120 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
HOMA-IR of controls and type 2 diabetic patients by sex, genotype, and level of exercise. *indicate P  = .05, #indicate P  = .03.
###end p 59
###begin p 60
###xml 21 29 <span type="species:ncbi:9606">patients</span>
Biomedical data from patients and controls displayed according to genotype at SNPs rs2267161. The serum sulfatide and insulin levels are in log units.
###end p 60
###begin p 61
The nucleotide frequencies at SNPs rs42929.
###end p 61

